Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological study
Open Access
- 1 January 2013
- journal article
- research article
- Published by SAGE Publications in Pharmacognosy Magazine
- Vol. 9 (34) , 176-81
Abstract
Background: Vedic Guard is a polyherbal formulation used in the treatment of various ailments, however, is not scientifically assessed for its effect on doxorubicin-induced cardiotoxicity. Objective: To find out the preventive role of Vedic Guard against doxorubicin-induced myocardial toxicity in rats. Materials and Methods: Cardiotoxicity was produced by doxorubicin (15 mg/kg for 2 weeks). Vedic Guard (270 mg/kg, orally) was administered as pre-treatment for 2 weeks and then for 2 weeks alternated with doxorubicin (DXR). The general observations, mortality, histopathology, biomarker like lactate dehydrogenase (LDH), creatine phosphokinase (CPK), aspartate aminotransferase (AST), alanine transaminase (ALT), electrocardiographic (ECG) parameters, antioxidants such as glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were monitored after 3 weeks of last dose. Results: The repeated administration of DXR causes cardiomyopathy associated with an antioxidant deficit. Pre-treatment with Vedic Guard decreases serum enzyme viz LDH, CPK, AST, and ALT levels to that of normal values. Vedic Guard significantly protected the myocardium from the toxic effect of DXR, by increasing the levels of antioxidants such as GSH, SOD, and CAT and decreased the elevated level of malondialdehyde. The study shows significant alteration of ECG pattern in DXR administered rats. The characteristic findings were elevation of ST segment, reduction in P waves, QRS complex, and R-R interval. Vedic Guard showed a protective effect against DXR-induced altered ECG pattern. It also reduced the severity of cellular damage of the myocardium confirmed by histopathology. Conclusion: The results of the present study indicated c ardioprotective effect of Vedic Guard might be attributed to its antioxidant activity.Keywords
This publication has 23 references indexed in Scilit:
- Protective role of phyllantus niruri extract in doxorubicin-induced myocardial toxicity in ratsIndian Journal of Pharmacology, 2011
- Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats.2009
- Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicityJournal of Ethnopharmacology, 2008
- The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in ratsCell Biology and Toxicology, 2007
- Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in micePhytomedicine, 2006
- Acute and Chronic Cardiovascular Effects of Doxorubicin in the DogJournal of Cardiovascular Pharmacology, 1980
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959
- A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic TransaminasesAmerican Journal of Clinical Pathology, 1957